So-Hee Kang

Title: So-Hee Kang: Innovator in CCR2 Antagonist Compounds

Introduction

So-Hee Kang is a prominent inventor based in Daejeon, South Korea. She has made significant contributions to the field of medicinal chemistry, particularly in the development of compounds that target chemokine receptor 2 (CCR2). Her work is crucial for addressing various diseases, including rheumatoid arthritis and multiple sclerosis.

Latest Patents

So-Hee Kang holds a patent for "Piperazinyl 3-aminopyrrolidine derivatives as CCR2 antagonists." This invention relates to compounds that exhibit CCR2 antagonistic effects, which are beneficial for treating, preventing, or alleviating conditions such as rheumatoid arthritis, arteriosclerosis, multiple sclerosis, and asthma. The compounds described in her patent are characterized by a specific chemical formula and include various salts or isomers.

Career Highlights

Throughout her career, So-Hee Kang has worked with notable companies in the pharmaceutical industry, including Yang Ji Chemical Co., Ltd. and Han Wha Pharma Co., Ltd. Her expertise in medicinal chemistry has positioned her as a valuable asset in the development of innovative therapeutic solutions.

Collaborations

So-Hee Kang has collaborated with esteemed colleagues, including Jee Woong Lim and Jong-Hoon Kim. These partnerships have further enhanced her research and development efforts in the field of pharmacology.

Conclusion

So-Hee Kang's contributions to the development of CCR2 antagonists highlight her role as an influential inventor in the pharmaceutical industry. Her innovative work continues to pave the way for new treatments for various diseases.